Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03843021 · ClinicalTrials.gov registry record
Ventricular Assist Device (VAD) Infection Prevention Survey
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 208
- Enrollment target
NCT03843021 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 208 participants.
The verdict
NCT03843021 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 208 participants
- Enrollment target
Study Summary
Annually, more than 250,000 patients in the U.S. with end-stage heart failure stand to benefit from ventricular assist device (VAD) therapy. 60% of patients develop a healthcare-associated infection (HAI) within 90-days of implantation. The investigators long term goal is to develop and subsequently promote wide-scale adoption of evidence-based HAI prevention practices following durable VAD implantation. This will be done by addressing the following aims: Aim 1. Identify determinants of center-level variability in HAI rates. Aim 2. Develop a comprehensive understanding of barriers and facilitators for achieving low center HAI rates. Aim 3. Develop, iteratively enhance, and disseminate a best practices toolkit for preventing HAIs that accommodates various center contexts. The investigators will use a focused survey of U.S. VAD centers to identify determinants of center variation in 90-day HAI rates: * Process Factors (e.g., intranasal mupirocin), * Provider Factors (e.g., surgeon technique), * Device Factors (e.g., centrifugal vs. axial), * Center Factors (e.g., provider communication). Understanding the barriers and facilitators within individual centers for maximizing adoption of prevention measures would serve as the foundation for targeted improvement strategies. Without this knowledge, evidence-based, action-oriented recommendations will have limited local adoption and ultimately effectiveness in preventing HAIs after VAD implantation.
Interventions
- OTHER VAD Infection Prevention Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2019-05-29 |
| Est. Completion | 2022-12-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03843021
The ClinicalTrials.gov registry entry for NCT03843021 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VAD Infection Prevention Survey is the first listed.
NCT03843021 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03843021 about?
NCT03843021 is a clinical study titled "Ventricular Assist Device (VAD) Infection Prevention Survey". Annually, more than 250,000 patients in the U.S. with end-stage heart failure stand to benefit from ventricular assist device (VAD) therapy. 60% of patients develop a healthcare-associated infection (HAI) within 90-days of implantation. The investigators long term goal is to develop and subsequently...
What is the current status of trial NCT03843021?
This trial is currently completed. The enrollment target is 208 participants. The study started on 2019-05-29. Estimated completion is 2022-12-23.
What interventions are being tested in trial NCT03843021?
The interventions under investigation include: VAD Infection Prevention Survey (OTHER).
Who is sponsoring clinical trial NCT03843021?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.